CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed
Drug / intervention
meditationbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00000546
NCT00000546Phase 3Completed
CompareCT.gov

Stress Reduction and Atherosclerotic CVD in Blacks

National Heart, Lung, and Blood Institute (NHLBI)·interventional·Posted Oct 28, 1999·Updated Feb 18, 2016

In Brief

A Phase 3 clinical trial evaluating meditation for Cardiovascular Diseases and 4 related conditions. Completed.

Detailed Summary

To evaluate the effectiveness of stress reduction with Transcendental Meditation (TM) on left ventricular hypertrophy, left ventricular function, blood pressure, psychosocial stress and quality of life, and cardiovascular disease risk factors.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiovascular Diseases, Heart Diseases, Hypertension, Vascular Diseases, Coronary Disease
Countries--
Collaborators--

Timeline

Phase 3CompletedFinished
1994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 28, 1999
Enrollment StartMar 1, 1994
Study CompletionMay 1, 2005
TodayJul 2, 2026
Posted 26.7 years ago

Interventions

meditationbehavioral